A Coeliac Revolution: On the cusp of real change. Dr James Daveson 30th August 2018 [Video]

Share on facebook
Share on twitter
Share on linkedin
Play Video

The reality of a potential treatment for coeliac disease beyond a gluten-free diet could be on the horizon with several therapies in differing stages of clinical trials. On Thursday 30th August 2018,  Wesley Medical Research held a special seminar to explore the exciting clinical trials that are happening on-site and across the globe.

‘A Coeliac Revolution; on the cusp of real change’ showcased Gastroenterologist and expert in coeliac disease, Dr James Daveson. Dr Daveson is actively involved in global research and will provide an update on new diagnostic testing and novel management therapies that could transform a coeliac diagnosis.

Coeliac disease is recognised as the most common of the autoimmune conditions, affecting one in 70 Australians. With 80% of cases undiagnosed, finding less invasive diagnostic testing and understanding the triggers for its development, are crucial to managing the condition ongoing.

Coeliac disease symptoms can be varied and challenging to diagnose. The new point-of-care test, a quick pin-prick method, is currently being explored at Wesley Medical Research with the generous support of the Thorsen Foundation. The impact of this testing could lead to a simpler, faster diagnosis at the GP practice – an important step in preventing further complications from the auto-immune disease which is triggered by gluten.

Currently, there is no cure for Coeliac Disease. The only medical treatment is to follow a strict gluten-free diet for life

Wesley Medical Research invites you to watch Dr Daveson’s full presentation of A Coeliac Revolution, where he explored the current landscape of Coeliac Disease and discussed future research that could drastically revolutionise treatment methods.

The Advocates Event: A Coeliac Revolution was held on Thursday 30th August, 2018 in the Evan and Mary Thomson Auditorium, Wesley Hospital. 

The event would not have been possible without the support of the Rosalie Martin Memorial Fund.

More to explore...

Hope for Better Quality of Life for Tourette’s Patients

After trying a dozen different medications, Chris, a Brisbane man who was diagnosed with debilitating Tourette’s Syndrome at age 12, is part of an Australian-first medicinal cannabis trial. For the past 16 years, the condition has impacted all aspects of Chris’ life, including his mental health. This trial has offered Chris more than hope. It’s offered a future.

Read More »

Wesley Medical Research

Scroll to Top